ARTICLE | Clinical News
Zilver PTX regulatory update
August 17, 2009 7:00 AM UTC
Cook said it received CE Mark approval last month for its Zilver PTX drug-eluting peripheral stent to treat peripheral artery disease (PAD) affecting the superficial femoral artery (SFA). The company ...